Use of rFVIIa in two children presenting major bleeding not controlled by the usual treatments before emergent surgery.
Guyot
Eliane
E
Carillion
Aude
A
Poli-Mérol
Marie-Laurence
ML
Ferrand
Isabelle
I
Chauvet
Philippe
P
Nguyen
Philippe
P
Malinovsky
Jean-Marc
JM
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000150:complications / Q000601:surgery; D002648:Child; D004750:Enteral Nutrition; D015942:Factor VIIa / Q000627:therapeutic use*; D005774:Gastrostomy; D006391:Hemangioma / Q000150:complications / Q000601:surgery; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D010535:Laparoscopy; D008297:Male; D008527:Medulloblastoma / Q000150:complications / Q000601:surgery; D011183:Postoperative Complications / Q000601:surgery; D011994:Recombinant Proteins / Q000627:therapeutic use; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013160:Splenic Neoplasms / Q000150:complications / Q000601:surgery
D000925:Anticoagulants; D011994:Recombinant Proteins; D006493:Heparin; D015942:Factor VIIa